425: Strive & Semler Scientific Merger Update

Strive, Inc. provides a cautionary statement regarding its proposed business combination with Semler Scientific, Inc., highlighting various risks and forward-looking statements.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination, which was the subject of a communication reposted by Strive's Chief Risk Officer on December 30, 2025.
• The communication serves as a cautionary statement, emphasizing that forward-looking statements about the merger's outlook, strategic/financial benefits, timing, and integration are subject to inherent risks and uncertainties.
• Key risks include the possibility of the transaction not closing as expected, integration difficulties, non-realization of anticipated benefits (including those from Bitcoin treasury strategies), and potential legal proceedings.
• Investors are strongly advised to review comprehensive SEC filings, such as Strive's Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus, for detailed information before making investment decisions.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement regarding a proposed merger, emphasizing numerous risks and uncertainties. While it acknowledges potential benefits, the overwhelming focus is on potential negative outcomes and the need for investor caution, leading to a slightly negative to neutral sentiment.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits, including potential cost savings and strategic gains for the combined company.

Negatives

• Potential for the proposed transaction to be more difficult, time-consuming, or costly than initially expected.
• Risk of dilution for Strive shareholders due to the issuance of additional Class A common stock in connection with the merger.
• Diversion of management's attention from ongoing business operations and opportunities during the merger process.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement between Strive and Semler Scientific.
• The possibility that the proposed transaction may not close as expected or at all, due to conditions to closing not being met or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact anticipated benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, including anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the businesses. However, these statements are subject to inherent risks and uncertainties, and actual results could differ materially from projections.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted this communication on X.com in connection with the proposed business combination.

Industry Context

This communication is specific to the proposed merger between Strive and Semler Scientific and does not provide broader industry trends or competitive analysis. However, the mention of 'Bitcoin treasury strategies and other digital assets' suggests an evolving financial landscape where companies are exploring new asset classes, which could be a relevant industry trend for Strive.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company could impact the proposed transaction.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock.
• Customers and employees of both Strive and Semler Scientific may experience adverse reactions or changes to business/employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive and Semler Scientific will continue to work towards satisfying the conditions to close the proposed business combination.
• Strive will issue Class A common stock in connection with the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant SEC documents.

Key Dates

Recommendation

The filing is a standard cautionary statement regarding a proposed business combination, outlining numerous risks and uncertainties. It does not present new financial results or operational updates that would fundamentally alter the investment thesis for either company at this stage. While the merger has potential strategic benefits, the detailed list of risks, including integration challenges, potential delays, and dilution, suggests a 'wait and see' approach. Investors should hold their positions and carefully review the comprehensive S-4 and proxy statement filings for a deeper understanding before making further investment decisions.

Keywords

Strive Inc, Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Investment, Bitcoin Treasury Strategy, Digital Assets